JP Patent

JP2017002048A — ピリミド［６，１−ａ］イソキノリン−４−オン化合物の結晶形態

Assigned to Verona Pharma Ltd · Expires 2017-01-05 · 9y expired

What this patent protects

【課題】ピリミド［６，１−ａ］−イソキノリン−３（４Ｈ）−イル］エチル｝ウレア系化合物（ＲＰＬ−５５４）の新規結晶多形の提供。【解決手段】特定のＸ線構造パラメータを有し、安定多形な式（１）で表される化合物。【選択図】なし

USPTO Abstract

【課題】ピリミド［６，１−ａ］−イソキノリン−３（４Ｈ）−イル］エチル｝ウレア系化合物（ＲＰＬ−５５４）の新規結晶多形の提供。【解決手段】特定のＸ線構造パラメータを有し、安定多形な式（１）で表される化合物。【選択図】なし

Drugs covered by this patent

Patent Metadata

Patent number
JP2017002048A
Jurisdiction
JP
Classification
—
Expires
2017-01-05
Drug substance claim
No
Drug product claim
No
Assignee
Verona Pharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.